TA

Transplantation and Cellular Therapy

Transplantation and Cellular Therapy is the official publication of the American Society for Transplantation and Cellular Therapy and focuses on the interdisciplinary field of hematopoietic cell transplantation and cellular therapies. The journal emphasizes clinical care, treatment outcomes, standards, best practices, evidence-based approaches, current technology, groundbreaking research, and clinical applications. It publishes original research reports, practice guidelines, reviews, editorials, commentaries, and letters to the editor.

Looking to publish in Transplantation and Cellular Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Hematology, Immunology, Transplantation
Impact Factor 4.4
Quartile Q1
Open Access Type Hybrid
ISSN 2666-6375
eISSN 2666-6367
Invitation Only No
Cost Range Open access APC: USD 4000 excluding taxes; subscription publication: no open access publication fee.

Submission Instructions

Transplantation and Cellular Therapy accepts the following article types. Click on an article type to view submission instructions.

Regular Manuscripts

Cover Letter Cover letter is required. Cover letter must identify the corresponding author’s name, address, phone number, fax number, and email address, and must specify the manuscript category and word count.
Abstract A structured abstract is required. Abstract must be 250 to 500 words. Abstract must be structured. Abstract headings must be Background, Objective(s), Study Design, Results, and Conclusion(s).
Manuscript Manuscript must be divided into clearly defined sections and organized to include Abstract, Introduction, Materials and Methods, Results, Discussion, Acknowledgments, References, Tables, Figure Legends, and Figures. Highlights are mandatory and must be provided as a separate editable file containing 3 to 5 bullet points, and authors must declare any use of generative AI in manuscript preparation upon submission if AI tools were used.
References References must follow AMA format. References must be cited with superscript Arabic numerals in the text and listed in numbered order of first appearance, with journal names abbreviated according to the List of Title Word Abbreviations.
Figures & Tables Figure files and table files must be uploaded individually in separate editable files. Figures must be cited in numerical order using Arabic numerals, and each table must be on a separate page, appropriately numbered, and accompanied by a legend sufficient to understand the data without referring to the text.
Reformat to Transplantation and Cellular Therapy using Livewrite Premium

Review Articles

Cover Letter Cover letter is required. Cover letter must identify the corresponding author’s name, address, phone number, fax number, and email address, and must specify the manuscript category and word count.
Abstract Abstract is required. Regular abstract is acceptable.
Manuscript Manuscript must be no more than 5,000 words exclusive of references. Manuscript must be divided into clearly defined sections and organized to include Abstract, Introduction, Materials and Methods, Results, Discussion, References, Tables, Figure Legends, and Figures. Highlights are mandatory and must be submitted as a separate editable file containing 3 to 5 bullet points of no more than 85 characters each, and any use of generative AI in manuscript preparation must be declared upon submission if applicable.
References References must not exceed 80. References must follow AMA format. References must be cited with superscript Arabic numerals in the order of appearance and listed numerically in that same order, with journal names abbreviated according to the List of Title Word Abbreviations.
Figures & Tables Figure files and table files must be uploaded individually in separate editable files. Figures must be cited in numerical order with legends on a separate page, and tables must be numbered and cited in numerical order with legends sufficient to make the data intelligible without reference to the text.
Reformat to Transplantation and Cellular Therapy using Livewrite Premium

Clinical Reviews

Cover Letter Cover letter is required. Cover letter must identify the corresponding author’s name, address, phone number, fax number, and e-mail address, and specify the manuscript category and word count.
Abstract A regular abstract is acceptable. Abstract may be unstructured as a regular abstract.
Manuscript Manuscript must be divided into clearly defined sections and organized as Cover Letter, Title Page, Financial Disclosure Statement, Abstract, Introduction, Materials and Methods, Results, Discussion, Acknowledgments, References, Tables, Figure Legends, and Figures. Highlights are mandatory and must be provided in a separate editable file as 3 to 5 bullet points of no more than 85 characters each, and any use of generative AI in manuscript preparation must be declared upon submission if applicable.
References References must follow AMA format. References must be cited with superscript Arabic numerals in the order of appearance and listed numerically in that same order, with journal names abbreviated according to the List of Title Word Abbreviations.
Figures & Tables Figure files and table files must each be uploaded individually in separate editable files. Figures must be numbered and cited in numerical order, figure legends must be double-spaced on a separate page with a brief title and concise explanation, and tables must be numbered with legends sufficient to make the data intelligible without reference to the text.
Reformat to Transplantation and Cellular Therapy using Livewrite Premium

Research Communications

Cover Letter Cover letter must identify the corresponding author’s name, address, phone number, fax number, and email address and specify the manuscript category and word count.
Abstract Abstract must not be included.
Manuscript Manuscript must not exceed 1,200 words. Manuscript must be written as a letter to the editor without section headings. Highlights must not be included.
References References are limited to a maximum of 5. References must follow AMA format. Citations must use superscript Arabic numerals in the order of appearance, and the reference list must be numbered in that same order with journal names abbreviated according to the List of Title Word Abbreviations.
Figures & Tables A maximum of 1 table or figure is allowed, and no more than 3 subfigures may be included. Figures and tables must be uploaded individually in separate editable files.
Reformat to Transplantation and Cellular Therapy using Livewrite Premium

Letters

Cover Letter Cover letter is required. Cover letter must provide the corresponding author's name, address, phone number, fax number, and e-mail address, and specify the manuscript category and word count.
Abstract Abstract is acceptable only if necessary for the letter. Regular abstracts are acceptable if an abstract is necessary.
Manuscript Letters must be no more than three double-spaced pages. Letters must have a title. Highlights are mandatory and must consist of 3 to 5 bullet points, and any use of generative AI in manuscript preparation must be declared upon submission.
References Letters may include no more than 10 references. References must follow AMA format. References must be cited with superscript Arabic numerals in the order of appearance and listed numerically in that same order, with journal names abbreviated according to the List of Title Word Abbreviations.
Figures & Tables Figure files and table files must be uploaded individually in separate editable files. Figures must be cited in numerical order using Arabic numerals, and table legends must provide enough explanation to make the data intelligible without reference to the text.
Reformat to Transplantation and Cellular Therapy using Livewrite Premium

Recent Publications

Short-Course Ruxolitinib Initiated at Neutrophil Engraftment for Prevention of Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter, Randomized, Open-Label, Controlled Phase II Trial

Huan Hua, Xuan Liu, Shupeng Wen, Ying Wang, Zhiyun Niu, Zhengrong Song, Ziwei Zhou, Li Sun, Zheng Xu, Jing Yuan, Xinzhi Han, Zhenzhen Wang, Feng Gao, Shuqing Feng, Guohong Su, Tao Wang, Liangming Ma, Jianping Zhang, Nannan Li, Hang Li, Xuejun Zhang, Fuxu Wang

10.1016/j.jtct.2026.10.031
View Publication

Recovery of a CMV-Reactive TCR from a Clinical Virus-Specific T-Cell Product for Generation of a Defined TCR-T Cell Product

Rotem Shachal, Amihai Lieberman, Nimrod Ben-Haim, Einav Vax, Sagi Berlinsky, Shlomit Teichman, Anat Shemer, Michael Rosenberg, Reut Ashwal-Fluss, Netta Zuckerman, Mor Hava Pereg, Michal Teperberg, Bella Bielorai, Etai Adam, Jonathan H. Esensten, Nira Varda-Bloom, Elad Jacoby, Ayal Hendel, Gal Cafri

10.1016/j.jtct.2026.10.034
View Publication

Transcriptional Signatures Associated with Etiology of Post-Hematopoietic Cell Transplant Lung Injury

John S. Goodman, Ian B. Stanaway, Melissa A. Krueger, Yeon Joo Lee, Lisa K. Vande Vusse, Alpana Waghmare, Guang-Shing Cheng, Sanjeet Dadwal, Michael Boeckh, Sina A. Gharib, Joshua A. Hill, Eric D. Morrell

10.1016/j.jtct.2026.10.030
View Publication

Allogeneic stem cells transplantation in children, adolescents and young adults previously treated by tisagenlecleucel for B-cell precursor acute lymphoblastic leukemia: a French retrospective SFGM-TC study

Marie Parreillet, Loic Vasseur, Florence Rabian, Karima Yakouben, Mony Fahd, Mustafa Alani, Marie Angoso, Marie Balsat, David Beauvais, Vincent Camus, Nathalie Cheikh, Florian Chevillon, Nathalie Contentin, Nathalie Garnier, Nathalie Dhedin, Miryam Mebarki, Catherine Paillard, Dominique Plantaz, Cécile Pochon, Fanny Rialland, Gabrielle Roth Guepin, Sandrine Visentin, Nicolas Boissel, André Baruchel, Jean-Hugues Dalle, Marie-Emilie Dourthe

10.1016/j.jtct.2026.10.038
View Publication

Longitudinal Recovery Trajectories of Instrumental Activities of Daily Living and Social Participation after Hematopoietic Stem Cell Transplantation: A Prospective Study

Koki Asai, Kentaro Iwata, Fumio Sakimoto, Jumpei Oba, Yoshimitsu Shimomura

10.1016/j.jtct.2026.10.039
View Publication

Frequently asked questions

How long does it take to publish?

3 days from submission to first decision; 29 days from submission to decision after review; 74 days from submission to acceptance; 5 days from acceptance to online publication.

Reformat to Transplantation and Cellular Therapy using Livewrite Premium

Is a cover letter required?

A cover letter is required. It should identify the corresponding author’s name, address, phone number, fax number, and e-mail address, specify the manuscript category and word count, include prior peer review information for Fast Track submissions, and indicate willingness to pay extra costs for color photographs when applicable.

Reformat to Transplantation and Cellular Therapy using Livewrite Premium

What are the publication costs?

Open access APC is USD 4000 excluding taxes for all articles. Subscription publication has no open access publication fee.

Reformat to Transplantation and Cellular Therapy using Livewrite Premium

Research Topics

Hematopoietic Stem Cell Transplantation CAR-T cell therapy research Acute Lymphoblastic Leukemia research Acute Myeloid Leukemia Research Renal Transplantation Outcomes and Treatments Chronic Myeloid Leukemia Treatments Multiple Myeloma Research and Treatments Chronic Lymphocytic Leukemia Research Lymphoma Diagnosis and Treatment Immune Cell Function and Interaction Childhood Cancer Survivors' Quality of Life Neutropenia and Cancer Infections Cytomegalovirus and herpesvirus research Polyomavirus and related diseases Transplantation: Methods and Outcomes Mesenchymal stem cell research Biomedical Ethics and Regulation Hemoglobinopathies and Related Disorders T-cell and B-cell Immunology Virus-based gene therapy research Myeloproliferative Neoplasms: Diagnosis and Treatment Immunotherapy and Immune Responses Biosimilars and Bioanalytical Methods Diverse Scientific and Economic Studies Immunodeficiency and Autoimmune Disorders

Related Journals

BP
Biological Psychiatry Global Open Science Elsevier BV
FA
Fertility and Sterility Elsevier BV
Va
Vaccines Multidisciplinary Digital Publishing Institute
ID
International Dental Journal Elsevier BV
AP
Acta Pharmaceutica Sinica B Elsevier BV
TL
The Lancet Planetary Health Elsevier BV